Aethlon Medical, Inc. (NASDAQ:AEMD) is reporting second quarter financial results on Wednesday 28th October 2020, after market close.
Stock Performance
Shares of Aethlon Medical, Inc. traded low $ -0.07 or -4.46 percent on Tuesday, reaching $ 1.50 with volume of 921.70 thousand shares. Aethlon Medical, Inc. has traded high as $ 1.64 and has cracked $ 1.44 on the downward trend
According to the previous trading day, closing price of $ 1.50, representing a 106.58 % increase from the 52 week low of $ 0.76 and a 65.11 % decrease over the 52 week high of $ 4.50.
The company has a market capital of $ 18.11 million and is part of the Technology sector and Scientific & Technical Instruments industry.
Conference Call
Aethlon Medical, Inc. will be hosting a conference call at 4:30 PM eastern time on 28th October 2020, to discuss its 2Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.aethlonmedical.com
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection.
